![](https://investorshub.advfn.com/uicon/64025.png?cb=1709342923)
Saturday, May 06, 2023 11:20:38 AM
The "Covid is Over" gang killed the funding opportunity for Phase III TolloVIR trial. You can't run one for free or $502
Why have antivirals when it's so easy to go to the hospital for a few weeks and suck O2?
Who cares that hospitalized Covid patients may end up with life long brain and organ damage? I've experience some of them first hand and their brain has been rattled from Covid as a number of studies have proven the impact of Covid.
For those that have fantastic insurance or already reached their high deductible, they can easily see 9 specialist after developing Long Covid. Maybe they can continue to see them for the rest of their lives?
This is a bad stock for traders. Traders should run far away. Stick with companies that have no products, services or revenue. Easier to manipulate the share price on those stocks.
When you hear about the upcoming TolloVid trial for Long Covid, please ignore.
![Bullish](/static/images/ih2-bull.png)
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM